Immix Biopharma Inc. Skyrocketed
Thu, Apr 27, 2023 at 07:12 PM
Immix Biopharma Inc. (IMMX:NASDAQ) soared at $2.3, representing a gain of 24.3%. On Thu, Apr 27, 2023, IMMX:NASDAQ hit a New 2-Week High of $2.3. The stock appeared on our News Catalysts scanner on Wed, Apr 26, 2023 at 05:43 PM in the 'BIOTECH' category. From Thu, Apr 13, 2023, the stock recorded 50.00% Up Days and 63.64% Green Days
About Immix Biopharma Inc. (IMMX:NASDAQ)
Immix Biopharma Inc is a clinical-stage biopharmaceutical company developing Tissue-Specific Therapeutics in oncology and inflammation.
Top 10 Gainers:
- Zhong Yang Financial Group Limited (TOP:NASDAQ), 197.62%
- Evelo Biosciences, Inc. (EVLO:NASDAQ), 101.1%
- Hillstream BioPharma Inc. (HILS:NASDAQ), 54.59%
- ContraFect Corporation (CFRX:NASDAQ), 46.97%
- Silence Therapeutics Plc (SLN:NASDAQ), 34.08%
- Atomera Incorporated (ATOM:NASDAQ), 32.76%
- U Power Limited (UCAR:NASDAQ), 32.19%
- Scopus BioPharma Inc. (SCPS:NASDAQ), 24.79%
- SAB Biotherapeutics Inc. (SABS:NASDAQ), 24.74%
- Immix Biopharma Inc. (IMMX:NASDAQ), 24.32%